Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2015—Rosetta Genomics has agreed to acquire CynoGen, which does business as PersonalizeDx, from Prelude Corp., a Fjord Ventures portfolio company. The acquisition is contingent upon the closing of Prelude’s purchase of PersonalizeDx from a third party.
June 2015—Beckman Coulter Diagnostics will distribute four new immunosuppressant drug user defined reagents as part of the company’s therapeutic drugs monitoring menu on its AU family of clinical chemistry systems.
June 2015—Microbiologics has entered into an agreement to source inactivated viruses from Microbix Biosystems. Microbiologics will incorporate these inactivated materials into a line of full process controls under its Helix Elite Molecular Standards brand as well as instrument-specific quality control sets.
June 2015—Thermo Fisher Scientific announced the release of the CE-IVD Oncomine Solid Tumour Fusion Transcript kit designed to aid clinical decision-making and enable highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin-embedded tumor samples.
June 2015—Enzo Biochem announced the development of the FlowScript assay in detection of messenger RNA from HPV oncogenes E6 and E7. The FlowScript technology platform is a proprietary flow-cytometry-based molecular detection system for the multiplex analysis of cell function and identity; the HPV E6/E7 assay is the first product to use this novel platform.
June 2015—The U.S. Patent and Trademark Office awarded a third U.S. patent to BioDot for its FISHArray technology and methods. BioDot’s patent family broadly covers technology and methods for performing multiple fluoresence in situ hybridization, immunohistochemistry, and cytogenetic tests on a single substrate, whether performed manually or through automated workstations, such as the company’s CellWriter Workstation.
June 2015—Oxford Immunotec announced the availability in the United States of a test that measures the strength of a patient’s cellular immune response to cytomegalovirus. The T-Spot.CMV test is available as a laboratory-developed test from the company’s CLIA-certified and CAP-accredited service laboratory.
June 2015—The Clinical and Laboratory Standards Institute has published a new document, “Process Management (QMS18-Ed1).” The guideline defines four requirements for managing laboratory processes and provides suggestions for meeting regulatory and accreditation requirements …
June 2015—Dako, an Agilent Technologies Company, announced a new master collaboration agreement with Amgen. The expanded collaboration will allow both companies to benefit from knowledge sharing within the field of drug-diagnostic research and development and in relation to companion diagnostic products.
June 2015—APiQ (Anatomic Pathology with Extra Intelligence) from Leica provides real-time laboratory workflow information on mobile devices. The initial release consists of two immunohistochemistry solutions: the APiQ Inventory Manager and the APiQ Instrument Dashboard.
